Insights & Publications | Articles
Excerpt from from the published article “Successes and Challenges in Clinical Trial Recruitment: The Experience of a New Study Team”
Recruitment and Retention in Global Clinical Research
Recruitment and retention of participants are central to the success of global clinical trials. Major multinational studies frequently experience delays or fail due to under-enrollment and poor retention, highlighting the necessity for sophisticated, globalized recruitment services.
Recruitment is Critical to The Success of Global Clinical Trials:
Direct Impact on Timelines and ROI: 86% of international clinical trials fail to meet recruitment targets within planned timelines, causing delays in drug development and increased operational costs.
Data Power and Validity: Underpowered studies due to inadequate enrollment or high dropout rates weaken results and may limit regulatory approval.
Global Diversity and Real-World Relevance: Trials lacking geographic and demographic diversity produce less generalizable findings, which can impede both regulatory success and health equity.
Why Global Recruitment Partners Are Essential
- Access to Diverse Populations: Global recruitment partners enable targeting across regions and underserved groups, strengthening trial diversity and scientific impact.
- Expedited Enrollment: Leveraging broad international networks and advanced technology, they accelerate participant enrollment and minimize costly delays.
- Regulatory Expertise: They provide crucial guidance on navigating complex, region-specific regulatory requirements in multi-country clinical research.
- Multimodal Outreach and Retention: Their expertise in digital, community, and provider engagement drives better patient participation and delivers culturally attuned support for improved retention.
Are you ready to accelerate your clinical research? Partnering with Clinical Research Advancement’s global recruitment services is the key to faster, more diverse, and highly impactful trials. By leveraging extensive networks, advanced digital tools, and in-depth local insights, we enable expedited enrollment, seamless regulatory navigation, and improved participant retention across the globe.
Collaborating with specialized global recruitment partners helps reduce costly delays, broaden patient diversity, and bring therapies to market more quickly. Now is the time to invest in strategic, scalable, and innovative solutions that drive clinical trial success.
Let’s unlock the future of clinical research together—connect with Clinical Research Advancement’s experts today and transform your trial outcomes. (Man Hung et al., 2024).
Reference:
Man Hung, A. Mohajeri, K. Almpani, G. Carberry, J. F. Wisniewski, K. Janes, … & F. W. Licari. (2024). Successes and challenges in clinical trial recruitment: The experience of a new study team.
Medical Sciences (Basel), 12(3), 39.
#ClinicalResearchAdvancement #InnovateClinicalResearch #PatientRecruitment #ClinicalTrialInnovation #TrialRetention #ResearchOpportunities
Clinical Research Advancement
Insights & Publications
Rates of COPD Diagnosis and Health Outcomes in at Risk Populations: An Insight to the Diagnosis of COPD
September 24, 2020
Author(s) Chen Y1, Gilliam Y2, Singh SS1, Jung S3, Fang H4 1Kantar, Singapore, Singapore, 2Kantar, Douglasville, Singapore, 3Kantar, Seoul, South Korea, 4Kantar Taiwan, Taipei, Taiwan
The Challenges and Unmet Needs in the Management of Hepatocellular Carcinoma (HCC) Patients and Burden of Advanced HCC across Hong Kong, Singapore and Thailand
September 24, 2020
Author(s) Yen C1, Ramaswamy B1, Baladi JF1, Acorda A2, Xu K2, Gilliam Y2, Gowindah R2, Singh SS2, Chen Y2 1Ipsen, Singapore, Singapore, 2Kantar, Singapore, Singapore
Uncovering the Hidden Burden of Depression: A Country Comparison
September 24, 2020
Author(s) Ken-Opurum J1, Fukuda T2, Chen Y3, Gilliam Y3, Stankus A4 1Kantar, Brooklyn, NY, USA, 2National Institute of Public Health, Wako-shi, 11, Japan, 3Kantar, Singapore, Singapore, 4Kantar, New York, NY, USA
APAC Overview of the Accelerated Approval Pathways: Applications in LUNG Cancer
September 24, 2020
Author(s) Johnson I1, Chou B1, Grillo V2, Sevilla M2, Singh SS2, Gilliam Y2 1Amgen, JAPAC, Hong Kong, Hong Kong, 2Kantar, Singapore, Singapore
Vaccination Rates Among the General Adult Population and High-Risk Groups in EU, US, JAPAN, South Korea and Taiwan
September 24, 2020
Author(s) Gilliam Y1, Teoh C2, Singh SS2, Chen Y2, Grillo V2 1Kantar, Douglasville, Singapore, 2Kantar, Singapore, Singapore
Hepatitis B and C: Differences in Diagnosis and Treatment
September 24, 2020
Author(s) Gilliam Y1, Singh SS1, Chen Y1, Kim J2, Fang H3 1Kantar, Singapore, Singapore, 2Kantar, Seoul, South Korea, 3Kantar Taiwan, Taipei, Taiwan
Clinical Research Advancement
Articles
Breaking Through Clinical Trial Barriers: When Recruitment Plans fail.
March 27, 2026
Many studies fall behind because initial enrollment assumptions don’t reflect real‑world patient flow, competing trials, or site capacity.
Why Africa Is the Next Big Frontier for Clinical Trials 2025–2030 Predictions
February 24, 2026
Africa is moving from “promising” to pivotal in clinical research.
Successes and Challenges in Clinical Trial Recruitment: The Experience of a New Study Team
February 10, 2026
Participant recruitment is one of the most challenging aspects of a clinical trial, directly impacting both the study’s duration and the quality of its results.
Precision, Relevance and Prediction: The Future of Clinical Trial Recruitment
January 22, 2026
The landscape of clinical trials is undergoing a profound transformation.
De-risking drug development: Ex-US clinical trials as a strategic advantage in 2025
September 9, 2025
The industry faces a significant dilemma in 2025 as it strives to maintain innovation amid growing global instability.
Improving access to innovative medicines in Africa starts with clinical trials
July 24, 2025
The global health community has long called for innovation that delivers impact where it is needed most.
Clinical Research Advancement Publications
ESMO Asia publication 2020, Annals of Oncology
ASCO GI PUBLICATION 2019_JCO
“Successes and Challenges in Clinical Trial Recruitment: The Experience of a New Study Team.”
Recruitment and Retention in Global Clinical Research
Recruitment and retention of participants are central to the success of global clinical trials. Major multinational studies frequently experience delays or fail due to under-enrollment and poor retention, highlighting the necessity for sophisticated, globalized recruitment services.
Recruitment is Critical to The Success of Global Clinical Trials:
Direct Impact on Timelines and ROI: 86% of international clinical trials fail to meet recruitment targets within planned timelines, causing delays in drug development and increased operational costs.
Data Power and Validity: Underpowered studies due to inadequate enrollment or high dropout rates weaken results and may limit regulatory approval.
Global Diversity and Real-World Relevance: Trials lacking geographic and demographic diversity produce less generalizable findings, which can impede both regulatory success and health equity.
Why Global Recruitment Partners Are Essential
- Access to Diverse Populations: Global recruitment partners enable targeting across regions and underserved groups, strengthening trial diversity and scientific impact.
- Expedited Enrollment: Leveraging broad international networks and advanced technology, they accelerate participant enrollment and minimize costly delays.
- Regulatory Expertise: They provide crucial guidance on navigating complex, region-specific regulatory requirements in multi-country clinical research.
- Multimodal Outreach and Retention: Their expertise in digital, community, and provider engagement drives better patient participation and delivers culturally attuned support for improved retention.
Are you ready to accelerate your clinical research? Partnering with Clinical Research Advancement’s global recruitment services is the key to faster, more diverse, and highly impactful trials. By leveraging extensive networks, advanced digital tools, and in-depth local insights, we enable expedited enrollment, seamless regulatory navigation, and improved participant retention across the globe.
Collaborating with specialized global recruitment partners helps reduce costly delays, broaden patient diversity, and bring therapies to market more quickly. Now is the time to invest in strategic, scalable, and innovative solutions that drive clinical trial success.
Let’s unlock the future of clinical research together—connect with Clinical Research Advancement’s experts today and transform your trial outcomes. (Man Hung et al., 2024).
Reference:
Man Hung, A. Mohajeri, K. Almpani, G. Carberry, J. F. Wisniewski, K. Janes, … & F. W. Licari. (2024). Successes and challenges in clinical trial recruitment: The experience of a new study team.
Medical Sciences (Basel), 12(3), 39.